Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report

Cellina, Michaela; D’Arrigo, Antonello; Floridi, Chiara; Oliva, Giancarlo; Carrafiello, Gianpaolo

doi:10.1016/j.clinimag.2021.10.010

Cited by 24 publications

(16 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three cases of Bell's palsy were reported following vaccination with mRNA-1273 vaccine (99)(100)(101). The symptoms appeared 12 hours to 2 days after the vaccine was administered.…”

Section: Mrna-1273 (Moderna) and Bell's Palsymentioning

confidence: 99%

COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review

et al. 2022

View full text Add to dashboard Cite

Despite their proven efficacy and huge contribution to the health of humankind, vaccines continue to be a source of concern for some individuals around the world. Vaccinations against COVID-19 increased the number of distressed people and intensified their distrust, particularly as the pandemic was still emerging and the populations were encouraged to be vaccinated under various slogans like “back to normal life” and “stop coronavirus”, goals which are still to be achieved. As fear of vaccination-related adverse events following immunization (AEFIs) is the main reason for vaccine hesitancy, we reviewed immune and autoimmune AEFIs in particular, though very rare, as the most worrisome aspect of the vaccines. Among others, autoimmune AEFIs of the most commonly administered COVID-19 vaccines include neurological ones such as Guillain-Barre syndrome, transverse myelitis, and Bell’s palsy, as well as myocarditis. In addition, the newly introduced notion related to COVID-19 vaccines, “vaccine-induced immune thrombotic thrombocytopenia/vaccine-induced prothrombotic immune thrombotic thrombocytopenia” (VITT/VIPITT)”, is of importance as well. Overviewing recent medical literature while focusing on the major immune and autoimmune AEFIs, demonstrating their rate of occurrence, presenting the cases reported, and their link to the specific type of COVID-19 vaccines represented the main aim of our work. In this narrative review, we illustrate the different vaccine types in current use, their associated immune and autoimmune AEFIs, with a focus on the 3 main COVID-19 vaccines (BNT162b2, mRNA-1273, and ChAdOx1). While the rate of AEFIs is extremely low, addressing the issue in this manner, in our opinion, is the best strategy for coping with vaccine hesitancy.

show abstract

“…Three cases of Bell's palsy were reported following vaccination with mRNA-1273 vaccine (99)(100)(101). The symptoms appeared 12 hours to 2 days after the vaccine was administered.…”

Section: Mrna-1273 (Moderna) and Bell's Palsymentioning

confidence: 99%

COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review

et al. 2022

View full text Add to dashboard Cite

show abstract

“…We believe that our patient had BPFP as a result of COVID-19, as there was a close relationship between this infection and facial nerve palsy and other secondary causes were excluded. In addition to SARS-CoV-2 infection, paralysis of this nerve is reported to be associated with anti-COVID-19 vaccination, although the pathophysiological mechanism remains unclear [ 15 , 16 ]. We hypothesized that the possible etiopathogenesis of facial paralysis in COVID-19 and post-vaccination patients is similar.…”

Section: Discussionmentioning

confidence: 99%